VALN
Valneva SE
NASDAQ · Healthcare · Biotechnology · FR
$6.89
−2.41%Margins
Gross margin
16.4%
EBITDA margin
-65.7%
EBIT margin
-80.9%
Net margin
-110.2%
FCF margin
-59.7%
-195.1%
Return on equity
-40.8%
Return on assets
-39.9%
Return on invested capital
0.38x
Asset turnover
-$96.7M
Cash from operations
$1.49
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026